Evidence mapPaperPMID 41682809Full record

ArticleJournal of clinical medicine2026

Reducing Polypharmacy-Related Adverse Outcomes in Older Adults with Chronic Kidney Disease: A Retrospective Cohort Study of a Digitally Mediated Pharmacist Intervention.

Keren Dopelt, Ori Mayer, Adir Dagan, Guy Melamed, Aviva Ben-Baruch, Inbal Yifrach-Damari, Tamar Ritte

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Keren DopeltDepartment of Public Health, Ashkelon Academic College, Ashkelon 78211, Israel.ORCID 0000-0003-4922-4155
Ori MayerDepartment of Cell and Developmental Biology, Gray Faculty of Medicine, Tel-Aviv University, Tel Aviv 69978, Israel.
Adir DaganDepartment of Cell and Developmental Biology, Gray Faculty of Medicine, Tel-Aviv University, Tel Aviv 69978, Israel.
Guy MelamedKahn-Sagol-Maccabi (KSM) Research & Innovation Institute, Maccabi Healthcare Services, Tel Aviv 67062, Israel.
Aviva Ben-BaruchDepartment of Quality Management, Health Division, Maccabi Healthcare Services, Tel Aviv 67062, Israel.
Inbal Yifrach-DamariDepartment of Pharmacy and Clinical Pharmacology, Health Division, Maccabi Healthcare Services, Tel Aviv 67062, Israel.
Tamar RitteDepartment of Quality Management, Health Division, Maccabi Healthcare Services, Tel Aviv 67062, Israel.

Funding

Kahn-Sagol-Maccabi (KSM) Research & Innovation Institute, Maccabi Healthcare Services 80/23
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adverse outcomesagedchronic kidney diseasemedication safetypharmacist-led interventionpolypharmacy

Identifiers

PMID41682809
PMCPMC12898421

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.